TickerFacts.

Emergent BioSolutions Inc. (EBS) — Cost of Revenue

Annual figures by period end, from SEC filings.

2016-12-31: $126.30M2017-12-31: $187.70M2018-12-31: $322.30M2019-12-31: $433.50M2020-12-31: $537.00M2021-12-31: $748.10M2022-12-31: $693.10M2023-12-31: $705.40M2024-12-31: $681.30M2025-12-31: $326.20M$326.20M
2016-12-31Cost of Revenue (USD)2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$326.20M-52.1%2026-02-27From 2025-01-01
2024-12-31$681.30M-3.4%2026-02-27From 2024-01-01
2023-12-31$705.40M+1.8%2026-02-27From 2023-01-01
2022-12-31$693.10M-7.4%2024-03-08From 2022-01-01
2021-12-31$748.10M+39.3%2024-03-08From 2021-01-01
2020-12-31$537.00M+23.9%2023-12-11From 2020-01-01
2019-12-31$433.50M+34.5%2021-02-19From 2019-01-01
2018-12-31$322.30M+71.7%2021-02-19From 2018-01-01
2017-12-31$187.70M+48.6%2020-02-25From 2017-01-01
2016-12-31$126.30M—2019-02-22From 2016-01-01